fig4
![Gut microbiome profiles associated with steatosis severity in metabolic associated fatty liver disease](https://image.oaes.cc/b2eb6a90-2703-47bc-a60d-c0bd84b4104d/4022.fig.4.jpg)
Figure 4. Differential abundance testing by DESeq2 showing genera that are different between (A) patients with advanced steatosis with or without elevated HbA1c, (B) patients without elevated HbA1c with or without advanced steatosis, and (C) patients with both advanced steatosis and elevated HbA1c as compared to those with neither.